Fasting-Mimicking Diet Fights Colorectal Cancer Through Gut Nerve Rewiring

Dietary interventions like fasting-mimicking diets have shown promise against multiple cancer types, but the biological mechanisms — particularly the role of the nervous system — have remained poorly understood. This study addresses that gap by examining how neural pathways mediate FMD's anti-tumor effects in colorectal cancer.

Researchers used a murine MC38 colorectal tumor model and applied cyclic FMD treatment over multiple rounds. Three-dimensional tissue imaging confirmed that colorectal tumors are richly innervated, establishing a structural basis for neural involvement in tumor biology. This neural density sets the stage for understanding how dietary signals could influence cancer via nerve pathways.

To dissect which neural routes matter, the team performed selective denervation procedures — removing enteric, vagal, sympathetic, and sensory nerve inputs independently. Strikingly, enteric denervation substantially weakened FMD's anti-tumor effect, while disrupting the vagus, sympathetic system, or sensory nerves made little difference. This pinpoints the enteric nervous system — the gut's intrinsic neural network — as a key mediator of FMD's cancer-suppressing actions.

Beyond the gut, central nervous system responses were mapped using c-Fos immunofluorescence. FMD triggered increased neuronal activation in the arcuate nucleus (a hypothalamic hub for metabolic sensing) and the insular cortex (linked to interoception), with altered activity also seen in the rostral ventrolateral medulla. This central signature suggests the brain is actively responding to and potentially orchestrating FMD's effects.

The findings are significant for longevity and oncology alike, implying that dietary interventions may work through neuroimmune and gut-brain axes rather than purely metabolic pathways. However, results are limited to mice, and the precise molecular signals linking enteric nerves to tumor suppression remain to be identified.